The Greek president contacted the CEO of Pfizer by phone and congratulated him for the rapid and reasonably rapid development of the vaccine against Kovid-19.
Pfizer CEO Albert Borla expected President Katerina Sakelopoulu that the vaccine would be available in a few weeks.
For his part, Sakelaproulou pointed out that everyone has a vaccine to contribute to the effective treatment of the epidemic.
On Monday, Pfizer announced that the experimental vaccine was more than 90% effective in preventing COVID-19, a major victory in the fight against the epidemic, based on preliminary data from a large study.
Greek-born Pfizer chairman and CEO Albert Borla said that “today is a great day for science and humanity” and he is “very happy.”
“But at the same time, sometimes I have tears in my eyes when I realize that it’s the end of nine months, the day-and-night work of so many people and how many people, billions, invested hopes on it Is … I never said that it would be 90%.
“We are potentially in a position to be able to provide some hope,” said Dr. Bill Gruber, Pfizer’s senior vice president of clinical development, The Associated Press. “We are very encouraged.”
The analysis was conducted after 94 participants of the trial developed Kovid-19, and observed how many of them received the vaccine and how many received a placebo that looked similar to the vaccine but had no effect. The patients did not know what they were receiving.
The study found that participants who received the 2-dose vaccine were protected from the virus 28 days after the start of vaccination.